Recent Quotes (30 days)

You have no recent quotes
chg | %

Premaitha Health PLC news

   Watch this stock
Showing stories 1 - 10 of about 81   

Articles published

NIPT 20.70 -0.92 (-4.28%)
price chart
Panmure Gordon Reconfirms GBX 31.00 Price Target On Premaitha Health Plc (LON ...
Research professionals at Panmure Gordon have GBX 31.00 PT on Premaitha Health Plc (LON:NIPT). Panmure Gordon's PT would indicate a potential upside of 21.57% from the company's close price.
Premaitha Health to join AIM as it prepares to launch first product
Subject to ViaLogy shareholders approval later this month, the enlarged business will be re-named Premaitha Health PLC and will become a listed company on the AIM platform.
ViaLogy Buys Molecular Diagnostic Company, But Struggles To Sell Energy Unit  London South East
Related articles »  
Panmure Gordon Reiterates Buy Rating for Premaitha Health PLC (NIPT)
Premaitha Health PLC logo Premaitha Health PLC (LON:NIPT)'s stock had its “buy” rating reissued by equities researchers at Panmure Gordon in a research report issued on Friday.
Premaitha Health PLC (Formerly ViaLogy PLC) ("Premaitha" or the "Company ...
... -- Premaitha's Admission and trading of its Ordinary Shares on AIM commences at 08.00hrs today (TIDM: NIPT). -- The Company has raised GBP 7.2 million by way of a Placing and Open Offer at a price of 11 pence per share.
Related articles »  
PEG Ratio (5 yr expected):
Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom.
Premaitha Health PLC Earns "Buy" Rating from Panmure Gordon (NIPT)
Premaitha Health PLC logo Panmure Gordon reissued their buy rating on shares of Premaitha Health PLC (LON:NIPT) in a research report released on Tuesday morning.
Premaitha Health PLC Rating Reiterated by Panmure Gordon (NIPT)
Premaitha Health PLC (LON:NIPT)'s stock had its “buy” rating reaffirmed by equities researchers at Panmure Gordon in a research report issued on Monday, MarketBeat.
Premaitha Health PLC Receives Buy Rating from Panmure Gordon (NIPT)  sleekmoney
Premaitha Health Says Laboratory Service Gets Regulator Accreditation  London South East
Illumina Files Patent Infringement Suit in the United Kingdom Against ...
SAN DIEGO, Mar 16, 2015 (BUSINESS WIRE) -- Illumina, Inc. ILMN, +0.20% today announced that it and its wholly-owned subsidiary, Verinata Health Inc., (together “Illumina”) have filed a patent infringement suit against Premaitha Health plc in the High ...
Esperite (ESP) and Premaitha Health sign a collaboration agreement for NIPT ...  Yahoo Finance UK
Premaitha Health PLC Earns Buy Rating from Panmure Gordon (NIPT)
Premaitha Health PLC (LON:NIPT)'s stock had its “buy” rating reaffirmed by stock analysts at Panmure Gordon in a report issued on Monday, AnalystRatings.
Leading London NHS Trust Teams up with Premaitha Health to Create the UK's ...
MANCHESTER, England & LONDON--(BUSINESS WIRE)--Premaitha Health plc (“Premaitha”, AIM: NIPT) and St George's University Hospitals NHS Foundation Trust (“St George's” or “the Trust”) announce today that Premaitha has been awarded the contract ...
London NHS Trust teams up with Premaitha Health to create the UK's first ...  European Pharmaceutical Review